Interfacial layer and coating solution for forming the same
AssigneeXerox Corporation
InventorsYuhua Tong, Edward F. Grabowski, Robert D. Bayley
Life of this patent
Estimating the term…
Abstract
The present embodiments are generally directed to an improved imaging member exhibiting various advantages over conventional imaging members. More specifically, the present embodiments are directed to an improved interfacial layer formed from an aqueous-based coating solution which exhibits improved formation and coating properties, such as increased homogeneity and adhesion, and methods for making the same. The aqueous-based coating solution is environment-friendly and avoids the need to use more expensive organic solvents which involve higher safety risks in the manufacturing process.
Claims18
A coating solution, comprising:
- a charge control agent;
- a surfactant;
- and
- a solvent, wherein the coating solution is aqueous-based and crosslinks to form an interfacial layer for an imaging member.
An imaging member comprising:
- a substrate;
- a charge blocking layer disposed on the substrate;
- an interfacial layer disposed on the charge blocking layer;
- and
- a charge imaging layer, wherein the adhesive interfacial layer is disposed between the charge blocking layer and the charge imaging layer, and further wherein the interfacial layer is crosslinked and formed from an aqueous-based coating solution comprising a charge control agent, a surfactant, and a solvent.
A coating solution for forming an interfacial layer, comprising:
- a charge control agent;
- a surfactant;
- a polyester resin;
- and
- a solvent, wherein the coating solution is aqueous-based and the polyester resin is a copolymer of terephthalic acid, dodecenylsuccinic anhydride, trimellitic acid, fumaric acid, Bisphenol A ethylenoxide adducts, and Bisphenol A propylenoxide adducts.
A coating solution for forming an interfacial layer, comprising:
- a charge control agent;
- a surfactant;
- and
- a solvent, wherein the coating solution is aqueous-based and the charge control aqent is selected from the group consisting of zinc salicylate, calcium salicylate, aluminum salicylate, chromium salicylate, boron salicylate, zirconium salicylate, iron salicylate, and mixtures thereof.
Dependencies are inferred from the claim text.